Skip to Content

UPSHER-SMITH 150 mg (Topiramate extended-release 150 mg)

Pill imprint UPSHER-SMITH 150 mg has been identified as Topiramate extended-release 150 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate extended-release 150 mg UPSHER-SMITH 150 mg
Discount Card Promo
Topiramate extended-release
Imprint:
UPSHER-SMITH 150 mg
Strength:
150 mg
Color:
Gray & Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Upsher-Smith Laboratories, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide